1-3 of 3
Adriana C Rossi, MD MHS
Close
Sort by
Journal Articles

Inhibition of CDK4/CDK6 Sensitizes Myeloma to IMiD By Reducing the MEIS2 to Cereblon Ratio That Accelerates IKZF1 and IKZF3 Degradation

Xiangao Huang, PhD, David Jayabalan, BSMS, MSc, Maurizio Di Liberto, PhD, Zhengming Chen, PhD, Anna C Schinzel, PhD, Scott Ely, MD MPH, Adriana C Rossi, MD MHS, Roger N Pearse, MD PhD, Ekta Aneja, MBBS, Morton Coleman, MD, Joseph M Lane, MD, William C. Hahn, MD PhD, Tomer M Mark, MD MSc, Ruben Niesvizky, MD, Selina Chen-Kiang, PhD
Journal: Blood
Blood (2015) 126 (23): 500.
https://doi.org/10.1182/blood.V126.23.500.500
Published: 2015
Journal Articles

Rising Plasma Cell Proliferation By Ki67/CD138 Ratio at Relapse Is a Marker of High Risk Disease in Multiple Myeloma

Peter A. Forsberg, MD, Tomer M Mark, MD MSc, Sujitha Yadlapati, MBBS, Adriana C Rossi, MD MHS, Roger N Pearse, MD PhD, Karen Pekle, NP, Arthur Perry, PA, Morton Coleman, MD, David Jayabalan, BSMS, MSc, Ruben Niesvizky, MD, Scott Ely, MD MPH
Journal: Blood
Blood (2015) 126 (23): 2991.
https://doi.org/10.1182/blood.V126.23.2991.2991
Published: 2015
Journal Articles

The Clinical Utility of Bone Resorption and Bone Formation Markers in Multiple Myeloma

Shahdabul Faraz, B.S., Roger N Pearse, MD PhD, Sujitha Yadlapati, MBBS, David Jayabalan, BSMS, MSc, Adriana C Rossi, MD MHS, Tomer M Mark, MD MSc, Ruben Niesvizky, MD, Joseph Lane, MD
Journal: Blood
Blood (2015) 126 (23): 5373.
https://doi.org/10.1182/blood.V126.23.5373.5373
Published: 2015